- Home
- RGNT vs YSXT Comparison
RGNT vs YSXT Comparison
Compare RGNT & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNT | YSXT |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | Israel | China |
| Employees | 8 | 39 |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.6M | 29.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RGNT | YSXT |
|---|---|---|
| Price | $3.90 | $1.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 13.7M | 18.8K |
| Earning Date | 05-05-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $0.93 |
| 52 Week High | $15.50 | $5.96 |
Technical Indicators
Market Signals| Indicator | RGNT | YSXT |
|---|---|---|
| Relative Strength Index (RSI) | 53.12 | 42.55 |
| Support Level | $1.95 | $0.98 |
| Resistance Level | $7.80 | $1.28 |
| Average True Range (ATR) | 2.17 | 0.09 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 18.79 | 10.64 |
Price Performance
Historical ComparisonAbout RGNT Regentis Biomaterials Ltd. Ordinary Shares
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.